Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
Clinical trial NCT00310037 · COMPLETED
Trial details
- NCT number
- NCT00310037
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2013-12-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.